Aspen Neuroscience, Inc. (ASPE)
Aspen Neuroscience, Inc. is a clinical-stage regenerative medicine biotechnology company, which engages in the development of autologous induced pluripotent stem cell (iPSC)-derived therapies to address neurodegenerative diseases. Its product candidate, sasineprocel, is an investigational single-dose, autologous iPSC-based cell therapy for the treatment of Parkinson's disease (PD). The company was founded by Jeanne F. Loring and Andrés Bratt-Leal in 2018 and is headquartered in San Diego, CA.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Aspen Neuroscience Inc.
NASDAQ:ASPEHealthcare · Biotechnology
PrePre-market-3.16%$14.42
Close$14.89AH$14.72-2.04%since
Mkt Cap$432.98M
Float17.82M
O/S29.08M
Vol
$ Vol
RVOL
Inst Own-
Earnings
Dilution
Financials Summary
No financial data available.
Debt & Equity
No debt & equity data available.
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:15Reverse splitJan 13, 200915 shares → 1
Balance Sheet Details
No balance sheet details available.
Income Statement
No income statement data available.
Balance Sheet
No balance sheet data available.
Cash Flow Statement
No cash flow data available.